59.0
Cognition Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
47.6
FY23:
34.2
FY24:
29.6
FY25:
48.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.15
FY22:
2.78
FY23:
0.94
FY24:
0.68
FY25:
0.40
Total assets
Change from FY21 to FY25
millions USD
FY21:
59.1
FY22:
50.4
FY23:
35.2
FY24:
30.2
FY25:
48.4
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
7.86
FY22:
7.80
FY23:
10.2
FY24:
11.1
FY25:
13.9
(negative)
millions USD
FY21:
0
FY22:
2.38
FY23:
0.52
FY24:
0.34
FY25:
0.20
(positive)
Change from FY21 to FY25
millions USD
FY21:
51.3
FY22:
40.2
FY23:
24.5
FY24:
18.8
FY25:
34.3
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
59.1
FY22:
50.4
FY23:
35.2
FY24:
30.2
FY25:
48.4
All amounts in millions USD